Visualant,
Inc. (OTCQB: VSUL), a leading provider of disruptive
light-based technologies, announced today the appointment of Dr. Richard
Mander to the position of Chief Technology Officer. Dr. Mander is being
promoted to Chief Technology Officer by the Visualant Board of Directors
in acknowledgement of his leadership in developing the Visualant
ChromaID™ platform and expanding the company’s intellectual property
portfolio.
ChromaID is a breakthrough light-based identification and measurement
technology, with the potential to disrupt traditional spectral analysis
and other costly methods of identification, authentication, and
diagnosis.
Mander brings a long history of success in the development of products
for the consumer and business-to-business marketplace. With a Ph.D. from
Stanford focusing on innovative interface technologies, he worked for
seven years at Apple transferring emerging technologies into successful
products. Since Apple he has held a variety of senior roles in consumer
electronics companies. In his most recent role he led the development of
the award winning Contour action-sports camera. Over the last year, as
Vice President of Product Management and Technology, Mander led the
development of Visualant’s ChromaID Scanner and Software Development Kit
which are designed to support developers who wish to explore and license
Visualant’s ChromaID technology.
“Richard has done a first class job bringing Visualant out of the lab
and into the marketplace,” said Ron Erickson, Visualant founder and CEO.
“The ChromaID Scanner and Software Developer Kit provide everything a
developer needs to explore and implement with our technology. Thanks to
Richard we now have the product in the hands of inventors and potential
users around the globe. Looking forward, I am excited to have Richard
drive the advance of our technology through our recently announced
partnership with Intellectual Ventures, third-party developers, and our
scientific team led by Professor Tom Furness.”
“I am thrilled to welcome Richard into the CTO role at Visualant and
look forward to working with him in advancing this amazing technology,”
said Prof. Furness.
“ChromaID is a very innovative technology and I am excited to bring it
to market,” said Dr Richard Mander, “It is truly exciting to see all the
applications unfolding for this technology both by our developers and
clients. I look forward to making Visualant’s ChromaID technology part
of people’s everyday lives.”
About Visualant, Inc.
Visualant™ is a public company whose shares trade under the stock symbol
“VSUL.” The Visualant Spectral Pattern Matching™ (SPM) technology
directs structured light onto a substance or material, through a liquid
or gas, or off a surface, to capture a unique ChromaID™. A ChromaID can
be used to identify, detect, or diagnosis markers invisible to the human
eye. ChromaID scanner modules can be integrated into a variety of mobile
or fixed-mount form factors. The patented, award-winning technology is
disruptive, making it possible to effectively conduct analyses in the
field that could only previously be performed by large and expensive
lab-based tests. For more information on Visualant, visit the company’s
new website at www.visualant.net.
Copyright Business Wire 2013